LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 555.83M
Enterprise Value 351.94M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)288.03
Price/Book (mrq)17.32
Enterprise Value/Revenue 3267.95
Enterprise Value/EBITDA 6-12.47

Trading Information

Stock Price History

Beta (3Y Monthly) 2.09
52-Week Change 3-64.36%
S&P500 52-Week Change 32.63%
52 Week High 32.0700
52 Week Low 30.6000
50-Day Moving Average 30.7383
200-Day Moving Average 30.9278

Share Statistics

Avg Vol (3 month) 374.65k
Avg Vol (10 day) 363.42k
Shares Outstanding 578.64M
Float 61.6M
% Held by Insiders 119.98%
% Held by Institutions 12.11%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/1
Last Split Date 3Dec 16, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug 31, 2018
Most Recent Quarter (mrq)May 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,167.48%

Management Effectiveness

Return on Assets (ttm)-85.17%
Return on Equity (ttm)-143.22%

Income Statement

Revenue (ttm)193.84k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-57.30%
Gross Profit (ttm)395.14k
EBITDA -4.17M
Net Income Avi to Common (ttm)-4.24M
Diluted EPS (ttm)-0.0550
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.07M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)19.71
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-3.11M
Levered Free Cash Flow (ttm)-2.18M